Prevalence and risk factors of malaria among children in southern highland Rwanda
- Jean-Bosco Gahutu†1Email author,
- Christian Steininger†2,
- Cyprien Shyirambere1,
- Irene Zeile2,
- Neniling Cwinya-Ay1,
- Ina Danquah2,
- Christoph H Larsen3,
- Teunis A Eggelte4,
- Aline Uwimana5,
- Corine Karema5,
- Andre Musemakweri1,
- Gundel Harms2 and
- Frank P Mockenhaupt2
© Gahutu et al; licensee BioMed Central Ltd. 2011
Received: 2 March 2011
Accepted: 18 May 2011
Published: 18 May 2011
Increased control has produced remarkable reductions of malaria in some parts of sub-Saharan Africa, including Rwanda. In the southern highlands, near the district capital of Butare (altitude, 1,768 m), a combined community-and facility-based survey on Plasmodium infection was conducted early in 2010.
A total of 749 children below five years of age were examined including 545 randomly selected from 24 villages, 103 attending the health centre in charge, and 101 at the referral district hospital. Clinical, parasitological, haematological, and socio-economic data were collected.
Plasmodium falciparum infection (mean multiplicity, 2.08) was identified by microscopy and PCR in 11.7% and 16.7%, respectively; 5.5% of the children had malaria. PCR-based P. falciparum prevalence ranged between 0 and 38.5% in the villages, and was 21.4% in the health centre, and 14.9% in the hospital. Independent predictors of infection included increasing age, low mid-upper arm circumference, absence of several household assets, reported recent intake of artemether-lumefantrine, and chloroquine in plasma, measured by ELISA. Self-reported bed net use (58%) reduced infection only in univariate analysis. In the communities, most infections were seemingly asymptomatic but anaemia was observed in 82% and 28% of children with and without parasitaemia, respectively, the effect increasing with parasite density, and significant also for submicroscopic infections.
Plasmodium falciparum infection in the highlands surrounding Butare, Rwanda, is seen in one out of six children under five years of age. The abundance of seemingly asymptomatic infections in the community forms a reservoir for transmission in this epidemic-prone area. Risk factors suggestive of low socio-economic status and insufficient effectiveness of self-reported bed net use refer to areas of improvable intervention.
Recent years have seen a substantial increase in malaria control activities. Particularly in East Africa, growing evidence suggests a decline in malaria transmission, morbidity and mortality over the last decade [1–5]. Control measures considered vital to this improvement are the deployment of artemisinin-based combination treatment (ACT), distribution of long-lasting insecticide-treated nets (LLINs), and indoor residual spraying [3, 6].
Rwanda is a prime example for the impact malaria control can have. Since 2000, several million insecticide treated nets (ITNs) have been distributed (mostly LLINs) increasing the percentage of the population (10 million) covered by nets to potentially ≥70%. In parallel, ACTs have been dispensed on a large scale. In 2007, 56% of households were considered to own a net and 56% of children to sleep under one . Surveillance and health facility based data indicate that by 2007-2008 these efforts were associated with approximately 50% or higher declines in confirmed outpatient cases, inpatient cases, and deaths due to malaria in children <5 years old [4, 7].
While this progress does not appear to be questionable, the extent of the declines as deduced from facility-based data might differ at community level. For instance, community-level case management programmes  have been reported to shift primary treatment from health centres to villages and thus decrease the health-facility burden . Such a trend, however, does not necessarily reflect the situation in the community [10, 11].
One aim of the present study was therefore to provide up-to-date malariologic data at the levels of community, health centre, and district hospital for a highland area in southern Rwanda from where no published material exists so far. In addition, the study aimed at identifying (modifiable) factors associated with Plasmodium infection and malaria in this population.
Study area and sampling
Rwanda has a mandatory health insurance system in which the mutual health insurance scheme (mutuelle de santé ) is the most widespread. At an annual cost of 1,000 Rwandan Francs (1.28 €; February 2010) per capita, treatment of common diseases is basically free of charge including utilization of district and provincial hospitals provided there is adherence to a strict referral system . Governmental health services in Butare area are provided by several primary health centres, Kabutare district hospital and Butare University Teaching Hospital (CHUB, Centre Hospitalier Universitaire de Butare ).
Brief questionnaires were filled in on socio-economic aspects of the children's families including household assets; specification of bed nets, e.g. impregnated or not, was omitted. All children were examined by a physician, a medical history obtained, and a venous blood sample collected. Age, sex, weight, height, mid-upper arm circumference (MUAC), and fever (axillary temperature ≥37.5°C) were documented. Haemoglobin (Hb) levels were measured by a HemoCue photometer (Angelholm, Sweden). Anaemia was defined as an Hb level < 11 g/dL. Intestinal parasites were screened for by direct wet mount microscopical stool examination, and urinary tract infection by dipstick (Multistix 10 SG, Bayer, Germany). Malaria parasites were counted per 200 white blood cells (WBCs) on Giemsa-stained thick blood films, while the patient was waiting. Children with malaria parasites were treated with artemether-lumefantrine. Other diseases were treated according to Rwanda health authority guidelines . Following duplicate readings per 200 WBCs at the CHUB central laboratory and the Institute of Tropical Medicine & International Health in Berlin, the definite parasite density was calculated on the basis of a putative mean WBC count of 8,000/μL. These data were used for analysis. Malaria was defined as any microscopically visible parasitaemia plus fever or a history of fever within the preceding 48 hours. DNA was extracted (Qiamp blood kit; Qiagen, Germany), and Plasmodium species and submicroscopic infections were identified by semi-nested multiplex polymerase chain reaction (PCR) assays . For all PCR positive samples, sequences corresponding to the allelic families of the Plasmodium falciparum merozoite surface protein 1 (msp1 ) block 2 (K1, Mad20, Ro33) and of msp2 block 3 (FC27, IC) were amplified in five separate PCR assays . Size variation within the alleles can be used to discriminate different parasite clones by PCR fragment length polymorphism, visualised on 3% GTG® -agarose gels (Biozym, Germany) and analysed using GeneSnap software (SynGene, UK). In case of negative or inconclusive PCR results, assays were repeated maximally twice. Multiplicity of infection (MOI) was calculated as the highest number of fragments for either msp1 or msp2. Residual (pre-treatment) concentrations of chloroquine and pyrimethamine (indicative of sulphadoxine-pyrimethamine) in plasma were determined by ELISA with limits of detection of 5 ng/mL and 10 ng/mL, respectively .
Data analysis was performed using Statview 5.0 (SAS Institute Inc.). Continuous variables were compared between groups by the non-parametric Mann-Whitney or Kruskal-Wallis tests, and proportions by χ2 test or Fisher's exact test. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were computed. Non-parametric ordinal regression analysis was performed to assess significantly differential effects of independent factors, e.g. infection, on a dependent variable, e.g. Hb levels, between groups. Despite non-parametric comparisons and for tangibility, parasite densities and Hb concentrations are displayed as geometric mean parasite densities (GMPDs) and means, respectively. Evaluation of determinants of P. falciparum infection and malaria was performed by logistic regression analysis. Stepwise backward selection was performed, and final models included those factors that retained statistical significance. A p-value < 0.05 was considered statistically significant.
Characteristics of 749 children from southern highland Rwanda
Sovu Health Centre
Kabutare District Hospital
Proportion girls (%)
Axillary temperature (°C)c
History of fever, last 2 days (%)
Anaemia (Hb < 11 g/dL),%
Severe Anaemia (Hb<7 g/dl),%
Primary diagnosis on examinationd
Gastro-intestinal tract affectione
Respiratory tract infection
Severe malnutrition (clinically)
Burns, wounds, accidents, etc.
Severe anaemia (clinically)
Urinary tract infection
Others, missing data
Selected socio-economic characteristics in 749 children from southern highland Rwanda
Sovu Health Centre
Kabutare District Hospital
Rural residence (%)
66.0 (66/100) *
Monthly family income (RwF)a
Mothers education (%)
Secondary or higher
11.7 (12/103) *
15.8 (16/101) *
Mother's occupation farmer/labourer (%)
92.2 (95/103) *
78.2 (79/101) *†
Father's education (%)
12.7 (13/102) *
19.8 (20/101) *
Father's occupation (%)
1.0 (1/101) *
No. of people/householda
5.0 (2-12) *
No. of siblingsa
1.4 (0-6) *
Household asset present (%)
11.7 (12/103) *
23.8 (24/101) *†
6.8 (7/103) *
37.6 (38/101) *†
67.0 (69/103) *
77.2 (78/101) *
5.9 (6/102) *
12.9 (13/101) *
24.3 (25/103) *
37.6 (38/101) *†
37.9 (39/103) *
27.7 (28/101) *
1.0 (1/102) *
2.0 (2/101) *
43.7 (45/103) *
20.8 (21/102) *†
Health insurance present (%)c
90.2 (92/102) *
79.3 (80/101) *†
Child received any drug in last 2 weeks
38.0 (38/100) *†
Child used bed net last night (%)
69.6 (71/102) *
73.3 (74/102) *
Chloroquine in plasma (%)
Parasitological parameters in 749 children from southern highland Rwanda
Sovu Health Centre
Kabutare District Hospital
GMPD (parasites/μL; 95%CI)
7603 (2127-27185) *
MOI (mean, range)
P. falciparum infection, PCR (%)
P. ovale infection, PCR (%)
P. malariae infection, PCR (%)
Proportion of submicroscopic infections (%, n/n)
Child received artemether-lumefantrine in last 2 weeks
Multiplicity of infection (MOI) was successfully typed for 88.8% (111/125) of all P. falciparum isolates. MOI ranged from one to five (mean, 2.02; median, 2.0); 65% (72/111) of infections were polyclonal (MOI >1). MOI did not differ between community children and those attending health facilities (Table 3), did not correlate with age (months; Spearman's r = 0.14; P = 0.33; community children only, r = 0.19, P = 0.20) but was increased in microscopically visible parasitaemia as compared to submicroscopic infections (means, 2.15 vs. 1.67; P = 0.03), correlated positively with parasite density (r = 0.28, P = 0.006), and tended to be reduced in former artemether-lumefantrine (AL) recipients as compared to children without such reported intake (means, 1.54 vs. 2.08; P = 0.06).
Factors associated with P. falciparum infection and malaria
Univariate and multivariate analysis of factors associated with P. falciparum infection (PCR)
Proportion infected (%)
>= 5000 RwF (median)
< 5000 RwF
Use of bed net
Intake of AL, preceding 2 weeks
Chloroquine in plasma
For malaria, the same analysis produced the following independently associated factors (aOR (95% CI)): age (months, 1.02 (1.0-1.05), P = 0.04), absent father (6.53 (2.15-19.83), P = 0.0009), presence of radio (0.30 (0.13-0.65), P = 0.003), recent intake of AL (4.40 (1.24-15.57), P = 0.02), and chloroquine in plasma (4.87 (1.43-16.57), P = 0.01), adjusted for attendance at health centre (15.93 (6.47-39.26), P < 0.0001) or district hospital (9.16 (3.16-26.52), P < 0.0001). The role of village among community children lost significance in multivariate analysis (all, P > 0.05). In the above final models, self-reported bed net use showed no association with P. falciparum infection (aOR, 0.88 (0.56-1.38), P = 0.58) or malaria (aOR, 0.99 (0.47-2.10), P = 0.98).
Limiting multivariate analysis to community children produced basically the same results. However, household possessions of cupboard or bicycle lost significant association with P. falciparum infection. In multivariate analysis of current malaria in community children, chloroquine in plasma (prevalence, 3.7%) lost significant association, and that of age (months) became borderline significant (aOR, 1.03; 95%CI, 1.0-1.07; P = 0.07).
Manifestation of malaria in rural Huye subdistrict
Anaemia (Hb < 11 g/dl)
1000 < 10000
> = 10000
P. falciparum infection, PCR
In children attending the health centre, there were trends only of an association between anaemia and P. falciparum infection by PCR (age-adjusted OR (95% CI), 2.77 (0.90-8.55), P = 0.08) or microscopically visible parasitaemia (2.69 (0.80-9.0), P = 0.11). In contrast, at the district hospital, these figures yielded statistical significance (PCR, 4.62 (1.34-15.95), P = 0.02; microscopy, 10.3 (1.89-55.88), P = 0.007). For fever, the opposite was seen: Parasitaemia, e.g. detected by microscopy, increased the risk of fever nine times in the health centre (age-adjusted OR (95% CI), 8.88 (2.54-31.04), P = 0.0006) but showed no association in the hospital (1.27 (0.30-5.39), P = 0.74).
Malaria transmission in Rwanda varies widely. Traditionally, the central plateau (altitude 1,500 to 1,800 m) is considered as one of four distinct ecological zones with overall P. falciparum prevalence rates of 5% to 15% . While transmission in Rwanda is regarded to be stable with seasonal peaks in the valleys and unstable (and potentially epidemic-prone) at higher altitude , a linear correlation between altitude and transmission would be over-simplified: in a recent tabulation of the years 2001-2007, endemicity at 1,600-2,000 m above sea level ranged from hypo-to holoendemic and annual malaria incidences (presumed and confirmed) from 2.4 to 20.4 per 1000 capita . Likely, these figures have declined in recent years [4, 7, 8]. Data from the 2007-2008 Demographic and Health Survey (DHS)  indicate that in >4,600 children <5 years of age and sampled across Rwanda, 2.6% had malaria infection based on rapid Plasmodium lactate dehydrogenase tests. In the present study from the vicinity of Butare (altitude, 1,768 m), 11% and 16% of community children were infected with P. falciparum based on microscopy and PCR, respectively. Data from the 2010 Rwanda Health Management Information System indicate that 13.4% of patients attending health facilities in the Huye district had microscopically confirmed malaria. In the present study, this figure was 12.3%.
Given the scarcity of published community-based data, the reasons for the discrepancy in the prevalence of infection reported in the DHS and observed in the present study are difficult to appraise. Higher sensitivity of PCR as compared to microscopy or rapid test devices [20, 21] may partially be involved. Selection bias during recruitment at home, e.g., due to preferential presentation by the parents of children with (a recent history of) sickness cannot completely be excluded. However, recruitment teams were instructed to select children from households randomly and into pre-defined age strata. Also, most infections in the communities were asymptomatic. One limitation of the present study is its cross-sectional nature by which e.g., seasonal fluctuations are not reproduced. Geographical variation of infection between villages was evident (Figure 2) but attempts to relate this to e.g. altitude or proximity to a water stream, failed. Likely involved, most villages comprise homesteads scattered in the hills rather than agglomerated settlements . Other parameters in the present study, e.g. self-reported bed net use, socio-economic factors, anaemia, were largely in the reported range [4, 19, 22]. Thus, the present data are not representative for the central plateau, let alone Rwanda, but rather provide a detailed and up-to-date picture of P. falciparum infection in southern highland communities and in health facilities serving this population. In contrast, routine health facility based surveillance has clear limitations in providing complete or representative data on e.g., malaria in the community, also because patients lacking access or choosing alternatives are not registered . A low health insurance coverage (43%) in the communities may have deterred parents from seeking formal health care. Such, in turn, could have lead to an over-estimation of disease burden at the community level as compared to the end of the year when more have paid their fees. Nevertheless, only 20% of African children with suspicion of malaria are considered to come to the attention of any formal health system , a figure that might have improved in recent years . Community-based surveys, despite their local limitations, thus provide essential information, also for control campaign monitoring [10, 11].
In the communities, infection prevalence increased from 10% to almost 25% at four years of age, which was not accompanied by a decline in parasite density with age or increase in MOI. The additional age-dependent increase in malaria and trend for declining asymptomatic infections indicate that semi-immunity did not develop to the extent observed in highly endemic areas [25–27]. In line with this, P. falciparum infection including submicroscopic ones had an impact on Hb levels, which exceeds the one commonly seen in children in high-endemicity areas [27–29]. On the other hand, only a quarter of parasitaemic children had malaria, suggesting a majority of asymptomatic infections. Irrespective of the erratic nature of fever in the definition of malaria, the presence of (usually undetected) asymptomatic P. falciparum infections has important implications for malaria control in highland areas. In two sites in highland Kenya, both, high and low levels of asymptomatic P. falciparum infections have been observed among children and adults [30, 31]. Studies from Ghana and Sudan indicate that asymptomatic infections can persist for a year or longer [32, 33]; in highland Kenya the median duration in children aged 5-9 years was five months . Gametocyte carriage was not consistently assessed in the present study but appeared to be low. Nevertheless, individuals with low level, long-lasting, and asymptomatic infections form a major reservoir for transmission [21, 34, 35]. In situations of increased rainfall, higher temperatures, or changed land use such asymptomatic infections may give rise to epidemics which have increased in frequency and intensity in East Africa during the last two decades [36–39]. Targeted antimalarial treatment even of asymptomatic children may thus be a justifiable part of malaria control in highland areas. However, the differing findings on the level of asymptomatic parasite carriage in the present and the two Kenyan studies [30, 31] illustrate that results may not be readily extrapolated.
At the health facilities, roughly half of the children had respiratory tract infections or gastrointestinal problems. Every sixth child at the health centre had malaria and every fifth was P. falciparum infected. Irrespective of the better socio-economic status of the patients' families as compared to the communities (Table 2) this indicates that malaria is among the top three reasons to seek primary health care in this area. At eight percent prevalence, malaria was of lesser importance at the district hospital which receives referrals from several health centres and patients bypassing the referral system by self-paying. There, 38% of the patients were reportedly pre-treated including 6% with AL. The validity of (malaria) treatment histories frequently is questionable , and no data on the dose and duration of treatment were collected in the present study. Nevertheless, the finding that recent AL treatment was positively associated with current malaria is remarkable. This is suggestive of recurrence of parasitaemia following treatment. In fact, drug resistance markers associated with reappearing parasitaemia following AL treatment tended to be increased in these infections (Zeile et al , unpublished observations). Latest cure rates of AL in Rwanda from 2006 have been reported as 97% . Nevertheless, against the background of intense AL drug pressure in Rwanda in recent years, this finding underlines the necessity of the upcoming re-evaluation of the drug's efficacy in this country.
Intake of chloroquine was stated by none of the respondents but the drug was present in plasma in 1.4% and 15.4% of non-infected and infected children, respectively. With the assay applied, chloroquine intake can be detected for several weeks, depending on the dose; cross-reactivity with amodiaquine is negligible . Likely, the finding of an increased infection prevalence in chloroquine positive children reflects the combination of previous home-treatment and persisting or recrudescent parasites due to intense chloroquine resistance which is prevalent in Rwanda .
Among the age-adjusted risk factors for P. falciparum infection was a decreasing MUAC. This crude proxy parameter for malnutrition was, however, not associated with malaria itself. Chronic malnutrition affects every second child in Rwanda  and compromises anti-pathogen immunity . Lacking effect on malaria morbidity as observed in the present study corresponds with previous findings [29, 44] but contrasts with others [28, 45, 46]. Possibly, the differential effect on infection and malaria depends on the specific yet unknown type of malnutrition in the study area. Considering the modifiable nature of this risk factor and Rwanda's recently renewed commitment to fight malnutrition, more research into this field is needed.
At variable statistical significance, several parameters reflecting low socio-economic status were associated with increased risks of infection. Remarkably, possession of a radio or a bicycle were independently associated predictors of reduced P. falciparum prevalence. This may reflect increased access to malaria-related information, improved awareness and increased usage of curative services. Given the latter is true, this points to accomplishable ways of reducing P. falciparum infection in the area, i.e. health communication and education.
Lastly, although self-reported bed net usage was in the previously observed range [4, 19, 22], the detectable impact was modest and non-significant in multivariate analysis. This finding points to deficits in an established mean of malaria prevention the efficacy of which has been confirmed in many studies [4, 7, 10, 11]. The reasons may be diverse and rather involve caregivers' beliefs about causation and vulnerability as well as obstacles in translating knowledge into behaviour than insecticide resistance [47–49]. Nevertheless, these actual reasons need to be assessed at the community-level and subsequent campaigns should address potential obstacles to promote consistent and correct use.
In this community and facility based survey on malariologic parameters in southern highland Rwanda, P. falciparum infection was observed in one out of six children under five years of age, without much variation between community and health facilities. While facility-based, most infections were symptomatic, the opposite was seen in the communities. These seemingly asymptomatic infections greatly contributed to anaemia and form an unrecognized source of transmission in the epidemic-prone highland area. Improved nutrition, identification and elimination of causes of low bed net effectiveness, and reinforced health education are promising and tangible measures to further reduce P. falciparum in this area of Rwanda. In parallel, community-based surveillance of malaria should be included to monitor the progress of malaria control.
The authors thank the children's families for participation in this study, and the staff at Sovu health centre, Kabutare district hospital, and CHUB central laboratory for assistance and cooperation. The active assistance by the Rwanda office of the German Development Cooperation (GIZ) is gratefully acknowledged. This study was supported by the German Federal Ministry for Economic Cooperation and Development via the ESTHER programme (Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau ). This work forms part of the theses of CSt and IZ.
- Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW: The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med. 2008, 5: e38-10.1371/journal.pmed.0050038.PubMed CentralView ArticlePubMed
- O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CRJC, Marsh K: Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet. 2008, 372: 1555-1562. 10.1016/S0140-6736(08)61655-4.PubMed CentralView ArticlePubMed
- Roll Back Malaria: The global malaria action plan. For a malaria-free world. 2008, Geneva, Switzerland
- World Health Organization: World malaria report. 2009, [http://www.who.int/malaria/world_malaria_report_2009/en/index.html]
- D'Acremont V, Lengeler C, Genton B: Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J. 2010, 9: 240-10.1186/1475-2875-9-240.PubMed CentralView ArticlePubMed
- Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, Bousema T, Drakeley CJ, Ferguson NM, Basáñez MG, Ghani AC: Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med. 2010, 7: e1000324-10.1371/journal.pmed.1000324.PubMed CentralView ArticlePubMed
- Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, Komatsu R, Korenromp E, Low-Beer D, Grabowsky M: Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J. 2009, 8: 14-10.1186/1475-2875-8-14.PubMed CentralView ArticlePubMed
- Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, Rich ML, Karema C, Daily JP: Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda. Malar J. 2008, 7: 167-10.1186/1475-2875-7-167.PubMed CentralView ArticlePubMed
- Tiono AB, Kaboré Y, Traoré A, Convelbo N, Pagnoni F, Sirima SB: Implementation of home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso. Malar J. 2008, 7: 201-10.1186/1475-2875-7-201.PubMed CentralView ArticlePubMed
- Rowe AK, Kachur SP, Yoon SS, Lynch M, Slutsker L, Steketee RW: Caution is required when using health facility-based data to evaluate the health impact of malaria control efforts in Africa. Malar J. 2009, 8: 209-10.1186/1475-2875-8-209.PubMed CentralView ArticlePubMed
- Rowe AK, Steketee RW, Arnold F, Wardlaw T, Basu S, Bakyaita N, Lama M, Winston CA, Lynch M, Cibulskis RE, Shibuya K, Ratcliffe AA, Nahlen BL: Roll Back Malaria Monitoring and Evaluation Reference Group: Viewpoint: evaluating the impact of malaria control efforts on mortality in sub-Saharan Africa. Trop Med Int Health. 2007, 12: 1524-1539. 10.1111/j.1365-3156.2007.01961.x.View ArticlePubMed
- Twahirwa A: Sharing the burden of sickness: mutual health insurance in Rwanda. Bull World Health Organ. 2008, 86: 823-824. 10.2471/BLT.08.021108.View ArticlePubMed
- Ministry of Health, Kigali, Rwanda: Protocoles des Services de Santé. [http://www.moh.gov.rw/index.php?option=com_docman&task=cat_view&gid=62&Itemid=14]
- Rubio JM, Post RJ, van Leeuwen WM, Henry MC, Lindergard G, Hommel M: Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg. 2002, 96 (Suppl 1): S199-204.View ArticlePubMed
- Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S: Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg. 1999, 93: 369-374. 10.1016/S0035-9203(99)90120-7.View ArticlePubMed
- Eggelte TA: Production of monoclonal antibodies against antimalarial drugs for use in immunoassays. The validation of chemical and immunochemical tests for antimalarials in body fluids. Edited by: Navaratnam V, Payne D. 1990, International Monograph Series 3. Penang, Malaysia: Universiti Sains Malaysia, 35-63.
- Rulisa S, Mens PF, Karema C, Schallig HD, Kaligirwa N, Vyankandondera J, de Vries PJ: Malaria has no effect on birth weight in Rwanda. Malar J. 2009, 8: 194-10.1186/1475-2875-8-194.PubMed CentralView ArticlePubMed
- Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, Van Overmeir C, van den Ende J, D'Alessandro U: Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg. 2003, 68: 743-747.PubMed
- Ministry of Health of Rwanda: Rwanda Interim Demographic and Health Survey 2007-2008. 2009, Ministry of Health of Rwanda, Kigali, Rwanda, [http://www.measuredhs.com/pubs/pdf/FR215/FR215.pdf]
- Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V, Ménard D: Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg. 2008, 78: 217-221.PubMed
- Okell LC, Ghani AC, Lyons E, Drakeley CJ: Submicroscopic infection in Plasmodium falciparum -endemic populations: a systematic review and meta-analysis. J Infect Dis. 2009, 200: 1509-1517. 10.1086/644781.View ArticlePubMed
- National Institute of Statistics of Rwanda: Districts Baseline Survey: Huye. 2007. 2009, National Institute of Statistics of Rwanda, Kigali, Rwanda, [http://statistics.gov.rw/index.php?option=com_content&task=view&id=158&Itemid=321]
- Oum S, Chandramohan D, Cairncross S: Community-based surveillance: a pilot study from rural Cambodia. Trop Med Int Health. 2005, 10: 689-697. 10.1111/j.1365-3156.2005.01445.x.View ArticlePubMed
- Breman JG: The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 2001, 64 (1-2 Suppl): 1-11.PubMed
- Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Pereira Da Silva L: The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg. 1994, 51: 123-137.PubMed
- Smith T, Felger I, Tanner M, Beck HP: Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg. 1999, 93 (Suppl 1): 59-64.View ArticlePubMed
- Mmbando BP, Segeja MD, Msangeni HA, Sembuche SH, Ishengoma DS, Seth MD, Francis F, Rutta AS, Kamugisha ML, Lemnge MM: Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania. Malar J. 2009, 8: 165-10.1186/1475-2875-8-165.PubMed CentralView ArticlePubMed
- Ehrhardt S, Burchard GD, Mantel C, Cramer JP, Kaiser S, Kubo M, Otchwemah RN, Bienzle U, Mockenhaupt FP: Malaria, anemia, and malnutrition in african children--defining intervention priorities. J Infect Dis. 2006, 194: 108-114. 10.1086/504688.View ArticlePubMed
- Danquah I, Dietz E, Zanger P, Reither K, Ziniel P, Bienzle U, Mockenhaupt FP: Reduced efficacy of intermittent preventive treatment of malaria in malnourished children. Antimicrob Agents Chemother. 2009, 53: 1753-1759. 10.1128/AAC.01723-08.PubMed CentralView ArticlePubMed
- John CC, McHugh MM, Moormann AM, Sumba PO, Ofulla AV: Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans R Soc Trop Med Hyg. 2005, 99: 780-786.View ArticlePubMed
- Baliraine FN, Afrane YA, Amenya DA, Bonizzoni M, Menge DM, Zhou G, Zhong D, Vardo-Zalik AM, Githeko AK, Yan G: High prevalence of asymptomatic Plasmodium falciparum infections in a highland area of western Kenya: a cohort study. J Infect Dis. 2009, 200: 66-74. 10.1086/599317.PubMed CentralView ArticlePubMed
- Franks S, Koram KA, Wagner GE, Tetteh K, McGuinness D, Wheeler JG, Nkrumah F, Ranford-Cartwright L, Riley EM: Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis. 2001, 183: 796-804. 10.1086/318834.View ArticlePubMed
- Nassir E, Abdel-Muhsin AM, Suliaman S, Kenyon F, Kheir A, Geha H, Ferguson HM, Walliker D, Babiker HA: Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int J Parasitol. 2005, 35: 49-55. 10.1016/j.ijpara.2004.10.014.View ArticlePubMed
- Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW: Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J. 2004, 3: 18-10.1186/1475-2875-3-18.PubMed CentralView ArticlePubMed
- Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH: Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J Med Entomol. 2005, 42: 777-779. 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2.View ArticlePubMed
- Lindblade KA, Walker ED, Onapa AW, Katungu J, Wilson ML: Land use change alters malaria transmission parameters by modifying temperature in a highland area of Uganda. Trop Med Int Health. 2000, 5: 263-74. 10.1046/j.1365-3156.2000.00551.x.View ArticlePubMed
- Hay SI, Were EC, Renshaw M, Noor AM, Ochola SA, Olusanmi I, Alipui N, Snow RW: Forecasting, warning, and detection of malaria epidemics: a case study. Lancet. 2003, 361: 1705-1706. 10.1016/S0140-6736(03)13366-1.PubMed CentralView ArticlePubMed
- Shanks GD, Hay SI, Omumbo JA, Snow RW: Malaria in Kenya's western highlands. Emerg Infect Dis. 2005, 11: 1425-1432.PubMed CentralView ArticlePubMed
- Checchi F, Cox J, Balkan S, Tamrat A, Priotto G, Alberti KP, Guthmann JP: Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis. 2006, 12: 1477-1485.PubMed CentralView ArticlePubMed
- Nwanyanwu OC, Redd SC, Ziba C, Luby SP, Mount DL, Franco C, Nyasulu Y, Chitsulo L: Validity of mother's history regarding antimalarial drug use in Malawian children under five years old. Trans R Soc Trop Med Hyg. 1996, 90: 66-8. 10.1016/S0035-9203(96)90482-4.View ArticlePubMed
- Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007, 101: 344-350. 10.1016/j.trstmh.2006.06.010.View ArticlePubMed
- East African Network for Monitoring Antimalarial Treatment (EANMAT): The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health. 2003, 8: 860-867.View Article
- Schaible UE, Kaufmann SH: Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007, 4: e115-10.1371/journal.pmed.0040115.PubMed CentralView ArticlePubMed
- Müller O, Garenne M, Kouyaté B, Becher H: The association between protein-energy malnutrition, malaria morbidity and all-cause mortality in West African children. Trop Med Int Health. 2003, 8: 507-511. 10.1046/j.1365-3156.2003.01043.x.View ArticlePubMed
- Deen JL, Walraven GE, von Seidlein L: Increased risk for malaria in chronically malnourished children under 5 years of age in rural Gambia. J Trop Pediatr. 2002, 48: 78-83. 10.1093/tropej/48.2.78.View ArticlePubMed
- Caulfield LE, Richard SA, Black RE: Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old. Am J Trop Med Hyg. 2004, 71 (2 Suppl): 55-63.PubMed
- Aikins MK, Pickering H, Greenwood BM: Attitudes to malaria, traditional practices and bednets (mosquito nets) as vector control measures: a comparative study in five west African countries. J Trop Med Hyg. 1994, 97: 81-86.PubMed
- Okrah J, Traoré C, Palé A, Sommerfeld J, Müller O: Community factors associated with malaria prevention by mosquito nets: an exploratory study in rural Burkina Faso. Trop Med Int Health. 2002, 7: 240-248. 10.1046/j.1365-3156.2002.00856.x.View ArticlePubMed
- Curtis CF, Maxwell CA, Magesa SM, Rwegoshora RT, Wilkes TJ: Insecticide-treated bed-nets for malaria mosquito control. J Am Mosq Control Assoc. 2006, 22: 501-506. 10.2987/8756-971X(2006)22[501:IBFMMC]2.0.CO;2.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.